CBRE Group (CBRE) Earnings Analysis
CBRE Group (CBRE) next reports earnings on 2026-07-29, consensus EPS 1.47 USD. Last quarter (2026-04-23) it beat with EPS 1.61 USD vs 1.13 USD est (+42.5%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E 31.16.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CBRE next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 1.47 USD |
| Revenue estimate | 11.18B |
CBRE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-23 | 1.61 USD | 1.13 USD | +42.5% | Beat |
| 2026-02-12 | 2.73 USD | 2.68 USD | +1.9% | Beat |
| 2025-10-23 | 1.61 USD | 1.46 USD | +10.3% | Beat |
| 2025-04-24 | 0.86 USD | 0.76 USD | +13.2% | Beat |
| 2025-02-13 | 2.32 USD | 2.2 USD | +5.5% | Beat |
| 2024-10-24 | 1.2 USD | 1.06 USD | +13.2% | Beat |
| 2024-07-25 | 0.81 USD | 0.709 USD | +14.2% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
CBRE valuation and analyst view
| Trailing P/E | 31.16 |
|---|---|
| Trailing EPS | 4.457 USD |
| Price / book | 4.74 |
| Dividend yield | 0.00% |
| Market cap | 39.92B |
| Analyst consensus | Buy (13 buy / 6 hold / 1 sell) |
| Avg price target | 175.33 USD |
Related research pages
Frequently asked questions
When is CBRE Group (CBRE)'s next earnings date?
CBRE Group is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 1.47 USD and revenue estimate of 11.18B.
Did CBRE beat earnings last quarter?
In its 2026-04-23 report, CBRE posted EPS of 1.61 USD versus a 1.13 USD estimate — a beat of 42.5%.
What is CBRE's earnings track record?
Over the last 7 reported quarters with consensus data, CBRE beat estimates 7 times (100%).
What is CBRE's current P/E ratio and EPS?
CBRE trades at a trailing P/E of 31.16 on trailing EPS of 4.456862452942819 USD.
What do analysts rate CBRE?
Analyst consensus is "Buy" across 20 ratings (0 strong buy, 13 buy, 6 hold, 1 sell, 0 strong sell). Average 12-month price target: 175.33 USD.